Similar articles

• Intracoronary thrombolysis in evolving myocardial infarction.

  Ganz W, Buchbinder N, Marcus H, Mondkar A, O'Connor L, Maddahi J, Berman D, Charuzi Y, Beeder C, Peter T, Shah PK, Shell W. Ganz W, et al. Herz. 1981 Feb;6(1):37-43. Herz. 1981. PMID: 7216121 No abstract available.
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).

  Peters RJ, Spickler W, Théroux P, White H, Gibson M, Molhoek PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD. Peters RJ, et al. Am Heart J. 2001 Aug;142(2):237-43. doi: 10.1067/mhj.2001.116759. Am Heart J. 2001. PMID: 11479461 Clinical Trial.
• Bleeding associated with antithrombotic therapy.

  Kelton JG, Hirsh J. Kelton JG, et al. Semin Hematol. 1980 Oct;17(4):259-91. Semin Hematol. 1980. PMID: 6160618 Review. No abstract available.
• [Fibrinolytics. 46].

  Wagler M. Wagler M. Pharm Prax. 1970;6:141-2. Pharm Prax. 1970. PMID: 4195438 Review. German. No abstract available.
• [Bolus fibrinolysis in acute myocardial infarction].

  Zeymer U. Zeymer U. Dtsch Med Wochenschr. 2002 Oct 4;127(40):2083-6. doi: 10.1055/s-2002-34511. Dtsch Med Wochenschr. 2002. PMID: 12373644 Review. German. No abstract available.